Early Development

Healixia_BAPU.jpgThe Belgian Association of Phase I Units (BAPU) was formed as a result of the EU Clinical Trials Directive of 2004 where a need was identified to create an umbrella organization for centers dedicated to Phase I clinical research. BAPU was born on 14 January 2005. 5 Academic Research Organisations, 2 Clinical Research Organisations and 2 company-owned organisations were the first members, and still are the current members.

The principal responsibilities include supporting its organisations in their work, representing their interests at regulators, provide a source of continued education through an internal education cycle as well as symposia.

Over time BAPU has extended its reach to close collaboration with sister organisations in Germany, France and the UK.

BAPU is also a member of Eufemed (= European Federation for Exploratory Medicines Development).

Early Development Domain within Healixia

Healixia ED Education Group.jpg

We can rely on our Healixia Early Development Education Group for the elaboration of our trainings/events/sessions on the topics with a link to Early Development. You can find the members here:

  • Jan De Hoon - UZ Leuven
  • Katrien Lemmens - SGS
  • Erik Mannaert - Janssen Pharmaceutica
  • Josue Mfopou Kunjom - Pfizer
  • Sylvie Rottey - UZ Gent
  • Annick Van Riel - SGS

Early Development agenda

  1. j-kelly-brito-PeUJyoylfe4-unsplash.jpg
    14 October '22

    Webinar: How to use the IB in de-risking FiH study


    More information will follow soon!

    Speaker: Prof. Dr. Jan de Hoon (UZ Leuven)

  2. Conference_web.jpg
    25 November '22

    Healixia seminar: From CTD to CTR - How to keep Belgium attractive for early phase development in EU

    Save the date!

    More information will follow soon.